Yoda Pharmaceuticals Inc. (TPEX:7829)
Taiwan · Delayed Price · Currency is TWD 46.40
+0.45 (0.98%)
At close: Sep 7, 2026
Yoda Pharmaceuticals Market Cap
Yoda Pharmaceuticals has a market cap or net worth of 4.61 billion as of September 8, 2026. Its market cap has decreased by -15.81% in one year.
Market Cap
4.61B
Enterprise Value
3.53B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
46.40
ChartMarket Cap Chart
Since June 3, 2025, Yoda Pharmaceuticals's market cap has increased from 2.92B to 4.61B, an increase of 58.07%. That is a compound annual growth rate of 43.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 3.68B | -20.82% |
| Dec 31, 2025 | 4.65B | 59.46% |
| Jun 3, 2025 | 2.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 6.53B |
| Alar Pharmaceuticals | 6.28B |
| Orient Pharma | 6.09B |
| Formosa Laboratories | 5.58B |
| Panion & Bf Biotech | 4.84B |
| LIWANLI Innovation | 4.66B |
| Orient EuroPharma | 3.99B |
| Easywell Biomedicals | 3.73B |